Drugs / Vax-DC/MM
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02248402 | Oct 2013 → Oct 2015 | plasma cell myeloma | Chonnam National University Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Vax-DC/MM | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02248402 ↗ |
| Modality | Cell therapy | “Cellular immunotherapy using dendritic cells” NCT02248402 ↗ |